POM Wonderful LLC
15
0
1
13
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
6.7%
1 terminated/withdrawn out of 15 trials
92.9%
+6.4% vs industry average
7%
1 trials in Phase 3/4
8%
1 of 13 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
Serial Brain MRI in Hospitalized Preterm Infants
Role: collaborator
Impact of Antioxidant Juice Intake on Brain Injury and Placental Pathology in Infants With Intrauterine Growth Restriction (IUGR)
Role: collaborator
Pomegranate Juice in Treating Patients With Recurrent Prostate Cancer
Role: collaborator
Study of Pomegranate Juice on Memory in Older Adults
Role: collaborator
Pomegranate Extract and Memory
Role: collaborator
Reversing Muscle Loss With Exercise Training and Daily Consumption of Pomegranate Juice
Role: collaborator
The Impact of Pomegranate Extract on Chronic Cardiomyopathy Complicated by Renal Insufficiency (ImPrOVE): a Pilot Study
Role: collaborator
Antioxidant Effects of Pomegranate Juice Versus Placebo in Adults With Type 2 Diabetes Mellitus
Role: collaborator
Impact of Maternal Pomegranate Juice on Brain Injury in Infants With Intrauterine Growth Restriction (IUGR)
Role: collaborator
POMx In the Treatment of Erectile Dysfunction
Role: lead
A Pilot Study to Evaluate the Effect of Pomegranate Juice on Semen Parameters in Healthy Male Volunteers
Role: lead
Safety and Efficacy of POMx Capsules in Men With Recurrent Prostate Cancer: An 18-Month Study
Role: lead
Pomegranate Extract Biomarker Study in Osteopenic Women
Role: lead
Trial to Evaluate the Use of Pomegranate Concentrate (POMx) for the Prevention of Experimental Rhinovirus Infection
Role: lead
Pomegranate Products for Prevention of Common Cold
Role: collaborator
All 15 trials loaded